Brasilina Caroccia
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Macrolide-Induced Aldosterone Suppression as a Functional Marker of KCNJ5-Mutated Aldosterone-Producing Adenoma: A Proof-of-Concept Clinical and Experimental Study (MAPA Study).
Journal: European journal of endocrinology
Published: March 12, 2026
Cytosolic Calcium Oscillations in Human Adrenocortical Cells Causing Primary Aldosteronism.
Journal: Molecular and cellular endocrinology
Published: February 26, 2026
Immune signatures associated with human adrenocortical hypertension.
Journal: European journal of endocrinology
Published: February 05, 2026
Angiotensin II Activates Yes-Associated Protein (YAP) in Fibroblast Promoting Deep Fascia Remodeling.
Journal: International journal of molecular sciences
Published: May 05, 2025
Water and Electrolyte Content in Hypertension in the Skin (WHYSKI) in Primary Aldosteronism.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: October 02, 2024
Subtype Identification of Surgically Curable Primary Aldosteronism During Treatment With Mineralocorticoid Receptor Blockade.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: March 25, 2024
Double CYP11B1/CYP11B2 Immunohistochemistry and Detection of KCNJ5 Mutations in Primary Aldosteronism.
Journal: The Journal of clinical endocrinology and metabolism
Published: March 15, 2024
Intracellular Calcium Dynamics in Primary Human Adrenocortical Cells Deciphered with a Novel Pipeline.
Journal: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension
Published: February 27, 2024
Water and Electrolyte Content in Salt-Dependent HYpertension in the SKIn (WHYSKI): Effect of Surgical Cure of Primary Aldosteronism.
Journal: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension
Published: November 16, 2023
A New Player in the Mechanobiology of Deep Fascia: Yes-Associated Protein (YAP).
Journal: International journal of molecular sciences
Published: August 20, 2023
RAndomized Clinical Trial Of NAfamostat Mesylate, A Potent Transmembrane Protease Serine 2 (TMPRSS2) Inhibitor, in Patients with COVID-19 Pneumonia.
Journal: Journal of clinical medicine
Published: August 17, 2023
Last Updated: 09/26/2026